NDC 64380-721-06 TACROLIMUS CAPSULES — Class III drug recall D-0180-2021
Terminated recall by Strides Pharma Inc., reported 2021-01-06, distributed in PA. Failed Moisture Limits
| Recall number | D-0180-2021 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Strides Pharma Inc., East Brunswick, NJ, United States |
| Recall initiated | 2020-12-22 |
| Classified | 2020-12-30 |
| Reported by FDA | 2021-01-06 |
| Terminated | 2022-01-26 |
| Distributed | PA |
| Quantity | 960 bottles |
| NDC | 64380-0720, 64380-0720-01, 64380-0720-06, 64380-0721, 64380-0721-01, 64380-0721-06, 64380-0722, 64380-0722-01, 64380-0722-06 |
| Lot numbers | 7242728A |
Product
NDC 64380-721-06 TACROLIMUS CAPSULES, USP 1mg 100 Capsules Rx Only Manufactured by: Strides Pharma Science Ltd. Bengaluru - 562106, India Distributed by: Strides Pharma Inc. East Brunswick, NJ 08816
Reason for recall
Failed Moisture Limits
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0180-2021. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.